These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32060845)

  • 1. The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment.
    Neo SY; Lundqvist A
    Adv Exp Med Biol; 2020; 1231():45-51. PubMed ID: 32060845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
    Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
    J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model.
    Walser TC; Ma X; Kundu N; Dorsey R; Goloubeva O; Fulton AM
    J Immunother; 2007; 30(5):490-8. PubMed ID: 17589289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL9: evidence and contradictions for its role in tumor progression.
    Ding Q; Lu P; Xia Y; Ding S; Fan Y; Li X; Han P; Liu J; Tian D; Liu M
    Cancer Med; 2016 Nov; 5(11):3246-3259. PubMed ID: 27726306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.
    Bronger H; Kraeft S; Schwarz-Boeger U; Cerny C; Stöckel A; Avril S; Kiechle M; Schmitt M
    Breast Cancer Res; 2012 Feb; 14(1):R30. PubMed ID: 22333315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
    Reynders N; Abboud D; Baragli A; Noman MZ; Rogister B; Niclou SP; Heveker N; Janji B; Hanson J; Szpakowska M; Chevigné A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
    Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
    J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment.
    Bikfalvi A; Billottet C
    Am J Physiol Cell Physiol; 2020 Mar; 318(3):C542-C554. PubMed ID: 31913695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
    Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
    Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and role of MIG/CXCR3 axis in mantle cell lymphoma.
    Zhu MX; Wan WL; Hong Y; Wang YF; Dong F; Jing HM
    Exp Cell Res; 2020 Dec; 397(2):112365. PubMed ID: 33197439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CXCL9/10/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity.
    Pan M; Wei X; Xiang X; Liu Y; Zhou Q; Yang W
    Clin Transl Oncol; 2023 Aug; 25(8):2306-2320. PubMed ID: 37076663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
    Müller M; Carter S; Hofer MJ; Campbell IL
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.
    Piali L; Weber C; LaRosa G; Mackay CR; Springer TA; Clark-Lewis I; Moser B
    Eur J Immunol; 1998 Mar; 28(3):961-72. PubMed ID: 9541591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
    House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
    Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of natural killer cells in advanced stages of endogenously arising B-cell lymphoma: implications for therapeutic cell transfer.
    Przewoznik M; Hömberg N; Naujoks M; Pötzl J; Münchmeier N; Brenner CD; Anz D; Bourquin C; Nelson PJ; Röcken M; Mocikat R
    J Immunother; 2012 Apr; 35(3):217-22. PubMed ID: 22421939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.
    Yano T; Ohira M; Nakano R; Tanaka Y; Ohdan H
    PLoS One; 2017; 12(10):e0186997. PubMed ID: 29088306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatomyositis and MIG.
    Ragusa F
    Clin Ter; 2019; 170(2):e142-e147. PubMed ID: 30993311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis and the Th1 chemokine MIG.
    Paparo SR
    Clin Ter; 2019; 170(6):e472-e477. PubMed ID: 31696912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of chemokine CXC receptor 3, 4 and their ligands at the early pregnancy decidua and villi].
    Bai XX; Kong BH; Zhang YZ; Qu X; Wang HL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):904-8. PubMed ID: 19134328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL9 chemokine in ulcerative colitis.
    Elia G; Guglielmi G
    Clin Ter; 2018; 169(5):e235-e241. PubMed ID: 30393811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.